Idiopathic pulmonary fibrosis: An epithelial/fibroblastic cross-talk disorder

Respiratory Research

Volumn 3, Issue , 2001, Pages

  Selman, Moisés ^a   Pardo, Annie ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Apoptosis; Epithelial cells; Extracellular matrix; Myofibroblasts; Pulmonary fibrosis

Indexed keywords

ANTIINFLAMMATORY AGENT; FAS ANTIGEN; FAS LIGAND; GELATINASE B; INTERSTITIAL COLLAGENASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL DAMAGE; CELL INTERACTION; CHRONIC LUNG DISEASE; DISEASE CLASSIFICATION; DRUG POTENCY; DRUG RESPONSE; EPITHELIUM CELL; EVIDENCE BASED MEDICINE; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; IDIOPATHIC DISEASE; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG FIBROSIS; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PNEUMONIA; REVIEW; TREATMENT FAILURE; WOUND HEALING IMPAIRMENT;

EID: 25444478849     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr175     Document Type: Review

References (48)

1. International consensus statement: Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000, 161:646-664.
2. Perez-Padilla R, Salas J, Chapela R, Sanchez M, Carrillo G, Perez R, Gaxiola M, Selman M: Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis 1993, 148:49-53
3. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP: Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 157:199-203.
4. Douglas WW, Ryu JH, Schroeder DR: Idiopathic pulmonary fibrosis. Impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000, 161: 1172-1178.
5. Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevaling and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001, 134:136-151.
6. Katzenstein ALA, Fiorelli RF: Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994, 18:136-147.
7. Borzone G, Moreno R, Urrea R, Meneses M, Oyarzun M, Lisboa C: Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001, 163:1648-1653.
8. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU: The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000, 162:2213-2217.
9. Katzenstein ALA, Myers JL: Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998, 157:1301-1315.
10. King TE, Sdchwarz MI, Brown K, Tose JA, Colby TV, Waldron JA, Flint A, Thurlbeck W, Cherniack RM: Extent of fibroblastic foci predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001, 163:A982.
11. Adamson IYR, Young L, Bowden DH: Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 1988, 130:377-383.
12. Regan W, Wold LE, Coonrad R, Morrey BF: Microscopic histopathology of chronic refractory lateral epicondylitis. Am J Sports Med 1992, 20:746-749.
13. Kraushaar BS, Nirschl RP: Tendinosis of the elbow (tennis elbow): clinical features and findings of histological, immunohistochemical, and electron microscopy studies. J Bone Joint Surg Am 1999, 81:259-279.
14. Kuhn C, III, Boldt J, King TE, Jr, Crouch E, Vartio T, McDonald JA: An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989, 140:1693-1703.
15. Kasper M, Haroske G: Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol 1996, 11:463-483.
16. Kapanci Y, Desmouliere A, Pache JC, Redard M, Gabbiani G: Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995, 152:2163-2169.
17. Nash JRG, McLaughlin PJ, Butcher D, Corrin B: Expression of tumour necrosis factor-α in cryptogenic fibrosing alveolitis. Histopathology 1993, 22:343-347.
18. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH: Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991, 5:155-162.
19. Khalil N, O'Connor RN, Flanders KC, Unruh HW: TGF-β1, but not TGF-β2 or TGF-β3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 1996, 14:131-138.
20. Antoniades NH, Bravo M, Avila R, Galanopoulus T, Neville J, Selman M: Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990, 86:1055-1064.
21. Kuhn C, McDonald JA: The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991, 138:1257-1265.
22. Fukuda Y, Basset F, Ferrans VJ, Yamanaka N: Significance of early intra-alveolar fibrotic lesions and integrin expression in lung biopsy specimens from patients with idiopathic pulmonary fibrosis. Hum Pathol 1995, 26:53-61.
23. Uhal BD, Joshi I, True AL, Mundle S, Raza A, Pardo A, Selman M: Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol 1995, 269: L819-828.
24. Wang R, Ramos C, Joshi I, Zagariya A, Pardo A, Selman M, Uhal B: Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J Physiol 1999, 277: L1158-L1164.
25. Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M: Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998, 275:L1192-L1199.
26. Barbas-Filho JV, Ferreira MA, Sesso A, Kairalla RA, Carvalho CR, Capelozzi VL: Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol 2001, 54:132-138.
27. Kuwano K, Miyazaki H, Hagimoto N, Kawasaki M, Fujita M, Kunitake R, Kaneko Y, Hara N: The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 1999, 20:53-60.
28. Maeyama T, Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N: Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur Respir J 2001, 17:180-189.
29. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G: Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994, 145:105-113.
30. Chodon T, Sugihara T, Igawa HH, Funayama E, Furukawa H: Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta 1 can abrogate this resistance. Am J Pathol 2000, 157:1661-1669.
31. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV: Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001, 107:87-96.
32. Lappi-Blanco E, Soini Y, Paakko P: Apoptotic activity is increased in the newly formed fibromyxoid connective tissue in bronchiolitis obliterans organizing pneumonia. Lung 1999, 177:367-376.
33. Ramos C, Montaño M, García-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A: Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and TIMPs expresion. Am J Respir Cell Mol Biol 2001, 24:591-598.
34. Jelaska A, Korn JH: Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum 2000, 43:2230-2239.
35. Jordana M, Schulman J, McSharry C, Irving LB, Newhouse MT, Jordana G, Gauldie J: Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 1988, 137:579-584.
36. Raghu G, Chen YY, Rusch V, Rabinovitch PS. Differential proliferation of fibroblasts cultured from normal and fibrotic human Lung. Am Rev Respir Dis 1988, 138:703-708.
37. Legrand C, Polette M, Tournier JM, de Bentzmann S, Huet E, Monteau M, Birembaut P: UPa/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Exp Cell Res 2001, 264:326-336.
38. Davis G, Pintar Allen K, Salazar R, Maxwell S: Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci 2001, 114:917-930.
39. Kotani I, Sato A, Hayakawa H, Urano T, Takada Y, Takada A: Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res 1995, 77:493-504.
40. Imokawa S, Sato A, Hayakawa H, Kotani M, Urano T, Takada A: Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. Am J Respir Crit Care Med 1997, 156:631-636.
41. Fujii M, Hayakawa H, Urano T: Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis. Thromb Res 2000, 99:111-117.
42. Saito Y, Suzuki E, Moriyama H, Terada M, Hasegawa T, Ooi H, Kobayashi Y, Tsuchiya T, Geivo F: Decreased ability to generate plasmin in lung tissue of usual interstitial pneumonia compared with bronchiolitis obliterans organizing pneumonia. Am J Respir Crit Care Med 2000, 161:A826.
43. Higgins PJ, Slack JK, Diegelmann RF, Staiano-Coico L: Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype. Exp Cell Res 1999, 248: 634-642.
44. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD: Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996, 149:1241-1256.
45. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N: Localization of matrix metalloproteinases-1, -2, and -9, and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998, 78:687-698.
46. Selman M, Ruiz V, Cabrera S, Segura L, Ramírez R, Barrios R, Pardo A: TIMP 1, 2, 3 and 4 in idiopathic pulmonary fibrosis. A prevailing non-degradative lung microenvironment? Am J Physiol 2000, 279:L562-L574.
47. Zhang K, Rekhter MD, Gordon D, Phan SH: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. Am J Pathol 1994, 145:114-125.
48. Parks WC, Sudbeck BD, Doyle GR, Saariahlo-Kere UK: Matrix metalloproteinases in tissue repair. In Matrix Metalloproteinases. Edited by Parks WC, Mecham RP. San Diego: Academic Press; 1998:263-297.